Annual Non Current Assets
$2.31 M
-$3.04 M-56.80%
December 31, 2023
Summary
- As of February 25, 2025, BCLI annual long term assets is $2.31 million, with the most recent change of -$3.04 million (-56.80%) on December 31, 2023.
- During the last 3 years, BCLI annual non current assets has fallen by -$5.71 million (-71.20%).
- BCLI annual non current assets is now -71.20% below its all-time high of $8.02 million, reached on December 31, 2020.
Performance
BCLI Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$1.66 M
-$206.00 K-11.03%
September 30, 2024
Summary
- As of February 25, 2025, BCLI quarterly long term assets is $1.66 million, with the most recent change of -$206.00 thousand (-11.03%) on September 30, 2024.
- Over the past year, BCLI quarterly non current assets has stayed the same.
- BCLI quarterly non current assets is now -79.28% below its all-time high of $8.02 million, reached on December 31, 2020.
Performance
BCLI Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
BCLI Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.8% | 0.0% |
| 3 y3 years | -71.2% | 0.0% |
| 5 y5 years | +141.0% | 0.0% |
BCLI Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.5% | at low | -74.6% | at low |
| 5 y | 5-year | -71.2% | at low | -79.3% | at low |
| alltime | all time | -71.2% | >+9999.0% | -79.3% | -100.0% |
Brainstorm Cell Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.66 M(-11.0%) |
| Jun 2024 | - | $1.87 M(-10.6%) |
| Mar 2024 | - | $2.09 M(-9.5%) |
| Dec 2023 | $1.90 M(-38.9%) | $2.31 M(-44.3%) |
| Sep 2023 | - | $4.14 M(-8.6%) |
| Jun 2023 | - | $4.53 M(-8.3%) |
| Mar 2023 | - | $4.94 M(-7.5%) |
| Dec 2022 | $3.11 M(-86.7%) | $5.34 M(-7.1%) |
| Sep 2022 | - | $5.75 M(-6.5%) |
| Jun 2022 | - | $6.16 M(-5.8%) |
| Mar 2022 | - | $6.53 M(+8.9%) |
| Dec 2021 | $23.28 M(-46.2%) | $6.00 M(-9.1%) |
| Sep 2021 | - | $6.59 M(-6.4%) |
| Jun 2021 | - | $7.05 M(-6.5%) |
| Mar 2021 | - | $7.54 M(-5.9%) |
| Dec 2020 | $43.24 M(+1187.0%) | $8.02 M(+240.6%) |
| Sep 2020 | - | $2.35 M(-9.2%) |
| Jun 2020 | - | $2.59 M(-9.5%) |
| Mar 2020 | - | $2.87 M(-9.7%) |
| Dec 2019 | $3.36 M(-67.3%) | $3.17 M(+1.1%) |
| Sep 2019 | - | $3.14 M(-5.7%) |
| Jun 2019 | - | $3.33 M(-7.4%) |
| Mar 2019 | - | $3.59 M(+275.2%) |
| Dec 2018 | $10.27 M(+6.7%) | $958.00 K(-16.6%) |
| Sep 2018 | - | $1.15 M(-21.2%) |
| Jun 2018 | - | $1.46 M(-5.9%) |
| Mar 2018 | - | $1.55 M(-14.0%) |
| Dec 2017 | $9.62 M(-7.9%) | $1.80 M(+368.8%) |
| Sep 2017 | - | $384.00 K(+20.4%) |
| Jun 2017 | - | $319.00 K(+3.9%) |
| Mar 2017 | - | $307.00 K(-4.7%) |
| Dec 2016 | $10.44 M(-37.8%) | $322.00 K(-4.5%) |
| Sep 2016 | - | $337.00 K(-1.2%) |
| Jun 2016 | - | $341.00 K(+12.2%) |
| Mar 2016 | - | $304.00 K(+4.1%) |
| Dec 2015 | $16.79 M(+75.3%) | $292.00 K(+9.0%) |
| Sep 2015 | - | $268.00 K(-11.3%) |
| Jun 2015 | - | $302.00 K(-2.3%) |
| Mar 2015 | - | $309.00 K(-7.2%) |
| Dec 2014 | $9.58 M(+115.4%) | $333.00 K(+13.7%) |
| Sep 2014 | - | $293.00 K(-7.6%) |
| Jun 2014 | - | $317.00 K(-6.8%) |
| Mar 2014 | - | $340.00 K(+21.4%) |
| Dec 2013 | $4.45 M | $280.00 K(-48.1%) |
| Sep 2013 | - | $540.00 K(+7.1%) |
| Jun 2013 | - | $504.00 K(+11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $452.00 K(+71.2%) |
| Dec 2012 | $4.87 M(+111.5%) | $264.00 K(-39.4%) |
| Sep 2012 | - | $436.00 K(-2.9%) |
| Jun 2012 | - | $449.00 K(-5.3%) |
| Mar 2012 | - | $474.00 K(+7.7%) |
| Dec 2011 | $2.30 M(+297.9%) | $440.00 K(-1.8%) |
| Sep 2011 | - | $448.00 K(-7.2%) |
| Jun 2011 | - | $483.00 K(-6.8%) |
| Mar 2011 | - | $518.00 K(+1.6%) |
| Dec 2010 | $579.00 K(+565.5%) | $510.00 K(-0.8%) |
| Sep 2010 | - | $514.00 K(-6.2%) |
| Jun 2010 | - | $548.00 K(-11.5%) |
| Mar 2010 | - | $619.00 K(-7.6%) |
| Dec 2009 | $87.00 K(+47.5%) | $670.00 K(-5.6%) |
| Sep 2009 | - | $710.00 K(-3.5%) |
| Jun 2009 | - | $736.00 K(-3.7%) |
| Mar 2009 | - | $764.00 K(-6.4%) |
| Dec 2008 | $59.00 K(-77.1%) | $816.00 K(-9.7%) |
| Sep 2008 | - | $904.00 K(-5.6%) |
| Jun 2008 | - | $958.00 K(-2.2%) |
| Mar 2008 | - | $980.00 K(+18.8%) |
| Dec 2007 | $258.00 K(+92.5%) | $825.00 K(+29.7%) |
| Sep 2007 | - | $636.00 K(+14.6%) |
| Jun 2007 | - | $555.00 K(-7.1%) |
| Mar 2007 | - | $597.70 K(+3.3%) |
| Dec 2006 | $134.00 K(-63.2%) | - |
| Sep 2006 | - | $578.50 K(-2.9%) |
| Jun 2006 | - | $595.50 K(+20.3%) |
| Mar 2006 | - | $495.20 K(+11.4%) |
| Mar 2006 | $364.60 K(-43.5%) | - |
| Dec 2005 | - | $444.60 K(-1.2%) |
| Sep 2005 | - | $450.20 K(+7.5%) |
| Jun 2005 | - | $418.90 K(+78.9%) |
| Mar 2005 | $645.20 K(>+9900.0%) | $234.20 K(>+9900.0%) |
| Dec 2004 | - | $1500.00(>+9900.0%) |
| Sep 2004 | - | $0.00(0.0%) |
| Jun 2004 | - | $0.00(-100.0%) |
| Mar 2004 | $0.00(-100.0%) | $16.20 K(-52.8%) |
| Dec 2003 | - | $34.30 K(+1.8%) |
| Sep 2003 | - | $33.70 K(+13.9%) |
| Jun 2003 | - | $29.60 K(-15.9%) |
| Mar 2003 | $10.30 K(-72.1%) | $35.20 K(-15.2%) |
| Dec 2002 | - | $41.50 K(-16.7%) |
| Sep 2002 | - | $49.80 K(-7.6%) |
| Jun 2002 | - | $53.90 K |
| Mar 2002 | $36.90 K | - |
FAQ
- What is Brainstorm Cell Therapeutics annual long term assets?
- What is the all time high annual non current assets for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual non current assets year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly non current assets year-on-year change?
What is Brainstorm Cell Therapeutics annual long term assets?
The current annual non current assets of BCLI is $2.31 M
What is the all time high annual non current assets for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual long term assets is $8.02 M
What is Brainstorm Cell Therapeutics annual non current assets year-on-year change?
Over the past year, BCLI annual long term assets has changed by -$3.04 M (-56.80%)
What is Brainstorm Cell Therapeutics quarterly long term assets?
The current quarterly non current assets of BCLI is $1.66 M
What is the all time high quarterly non current assets for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly long term assets is $8.02 M
What is Brainstorm Cell Therapeutics quarterly non current assets year-on-year change?
Over the past year, BCLI quarterly long term assets has changed by $0.00 (0.00%)